| NCT06592664 | Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC | WITHDRAWN | PHASE1, PHASE2 | 2030-01 | 2040-01 | 2035-01 |
| NCT05712356 | A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE2 | 2023-08-24 | 2030-03 | 2026-04-18 |
| NCT04990427 | CLBS201 in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM) | COMPLETED | PHASE1 | 2022-01-10 | 2023-01-26 | 2023-01-26 |
| NCT04614467 | A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction | TERMINATED | PHASE2 | 2020-10-29 | 2022-09-28 | 2022-09-28 |
| NCT04522817 | CLBS119 for Repair of COVID-19 Induced Pulmonary Damage | WITHDRAWN | PHASE1 | 2020-10-05 | 2021-05 | 2021-05 |
| NCT03517176 | CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer | COMPLETED | PHASE1 | 2018-07-31 | 2020-06-19 | 2020-06-19 |
| NCT03508609 | Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease | COMPLETED | PHASE2 | 2018-04-19 | 2020-05-05 | 2019-12-10 |
| NCT02501018 | Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI) | COMPLETED | PHASE2 | 2017-11-01 | 2022-05-19 | 2022-05-19 |
| NCT02691247 | Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study) | COMPLETED | PHASE2 | 2016-02 | 2020-01 | 2019-03 |
| NCT01875653 | Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma | TERMINATED | PHASE3 | 2014-10 | 2016-01 | 2016-01 |
| NCT01508910 | Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina | COMPLETED | PHASE3 | 2012-04 | 2015-11 | 2015-11 |
| NCT01495364 | NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction | COMPLETED | PHASE2 | 2011-12 | 2016-04 | 2014-06 |
| NCT00814593 | Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery | WITHDRAWN | PHASE2 | 2008-11 | 2011-09 | 2011-04 |
| NCT00300053 | ACT34-CMI -- Adult Autologous CD34+ Cells | COMPLETED | PHASE2 | 2006-04 | 2009-03 | 2008-03 |
| NCT00014131 | Vaccine Therapy in Treating Patients With Kidney Cancer | TERMINATED | PHASE1 | 2001-11 | 2009-12 | 2009-12 |
| NCT00012064 | Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma | COMPLETED | PHASE1, PHASE2 | 2000-07 | 2011-04 | 2011-04 |